MS6 Severe asthma: diagnosis and treatment

Morning Seminar
Chairs: K.F. Chung (London, United Kingdom)
Aims: To illustrate how to diagnose severe asthma in the clinic.
To demonstrate the advantages of using published definitions to define patient subsets.
To show how biomarker expression may determine therapy.

The BTS severe asthma cohort experience A. Menzies-Gow (London, United Kingdom)
Biomarkers and personalised treatment P. Chanez (Marseille, France)